Structure via PubChem · Public domain (PubChem)
آرفورموترول
Sign in to saveAlso known as Brovana®, YM-08316, (-)-formoterol, (R,R)-formoterol, (-)-Formoterol, Arformoterol
Arformoterol, sold under the brand name Brovana among others, is a medication used for the treatment of chronic obstructive pulmonary disease (COPD).
Key facts
- Drug.Verifiedfields
- changed
- Drug.verifiedrevid
- 457140599
- Drug.image
- Arformoterol.svg
- Drug.image_class
- skin-invert-image
- Drug.width
- 250
- Drug.image2
- Arformoterol ball-and-stick model.png
- Drug.image_class2
- bg-transparent
- Drug.USAN
- Arformoterol tartrate
- Drug.tradename
- Brovana
- Drug.MedlinePlus
- a602023
- Drug.DailyMedID
- Arformoterol
- Drug.routes_of_administration
- Inhalation
- Drug.ATC_prefix
- None
- Drug.legal_US
- Rx-only
- Drug.protein_bound
- 52–65%
- Drug.elimination_half life
- 26 hours
- Drug.CAS_number
- 67346-49-0
- Drug.PubChem
- 3083544
via Wikipedia infobox
Chemical data
- Formula
- C19H24N2O4
- Molecular weight
- 344.4 g/mol
- IUPAC name
- N-[2-hydroxy-5-[(1R)-1-hydroxy-2-[[(2R)-1-(4-methoxyphenyl)propan-2-yl]amino]ethyl]phenyl]formamide
- SMILES
- C[C@H](CC1=CC=C(C=C1)OC)NC[C@@H](C2=CC(=C(C=C2)O)NC=O)O
- InChIKey
- BPZSYCZIITTYBL-YJYMSZOUSA-N
- XLogP
- 1.8
- Polar surface area
- 90.8 Ų
- H-bond donors
- 4
- H-bond acceptors
- 5
- Formal charge
- 0
via PubChem
Drug data · ChEMBL
- Max clinical phase
- Approved
- Molecule type
- Small molecule
- First approval
- 2006
- Admin. routes
- topical
- Indications
- chronic obstructive pulmonary disease, emphysema, chronic bronchitis, bronchitis
via ChEMBL · EBI
Wikidata facts
- Mass
- 344.173607
- Has use
- medication
Show 7 more facts
- chemical formula
- C₁₉H₂₄N₂O₄
- canonical SMILES
- CC(CC1=CC=C(C=C1)OC)NCC(C2=CC(=C(C=C2)O)NC=O)O
- World Health Organisation international non-proprietary name
- arformoterol
- isomeric SMILES
- COC1=CC=C(C[C@@H](C)NC[C@H](O)C2=CC(NC=O)=C(O)C=C2)C=C1
- NCI Thesaurus ID
- C61641
- physically interacts with
- adrenoceptor beta 2
- Commons category
- Arformoterol
Sources (2)
via Wikidata · CC0